Teva v. Eli Lilly (Fed. Cir., April 16, 2026) 2024-1094
This episode concerns an opinion in which the United States Court of Appeals for the Federal Circuit addresses a patent dispute between Teva Pharmaceuticals and Eli Lilly regarding treatments for headaches. The court reversed a lower court's judgment that had invalidated Teva’s patents, which cover the use of specific humanized antibodies to inhibit a protein associated with pain. While the district court initially ruled that the patents lacked sufficient written description and enablement, the appellate court found that Teva provided enough detail for a skilled artisan to understand and…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.